Stocks
Procter & Gamble Financial Statements (PG) |
||||||||||
| Procter & Gamblesmart-lab.ru | % | 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 06.08.2021 | 30.06.2022 | 05.08.2022 | 30.06.2023 | 04.08.2023 | 19.04.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 76 118 | 80 187 | 80 187 | 82 006 | 82 006 | 84 060 | |||
| Operating Income, bln rub | 17 986 | 17 813 | 17 813 | 18 134 | 18 134 | 20 279 | ||||
| EBITDA, bln rub | ? | 20 852 | 21 190 | 21 241 | 21 823 | 21 823 | 23 690 | |||
| Net profit, bln rub | ? | 14 306 | 14 742 | 14 742 | 14 653 | 14 653 | 15 127 | |||
| OCF, bln rub | ? | 18 371 | 16 723 | 16 723 | 16 848 | 16 848 | 19 433 | |||
| CAPEX, bln rub | ? | 2 787 | 3 156 | 3 156 | 3 062 | 3 062 | 3 273 | |||
| FCF, bln rub | ? | 15 584 | 13 567 | 13 567 | 13 786 | 13 786 | 16 160 | |||
| Dividend payout, bln rub | 8 263 | 8 770 | 8 770 | 8 999 | 8 999 | 9 152 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 57.8% | 59.5% | 59.5% | 61.4% | 61.4% | 60.5% | ||||
| OPEX, bln rub | 21 024 | 20 217 | 20 217 | 21 112 | 21 112 | 22 669 | ||||
| Cost of production, bln rub | 37 108 | 42 157 | 42 157 | 42 760 | 42 760 | 41 113 | ||||
| R&D, bln rub | 1 900 | 0.000 | 2 000 | 0.000 | 2 000 | 2 000 | ||||
| Interest expenses, bln rub | 502.0 | 439.0 | 439.0 | 756.0 | 756.0 | 1 063 | ||||
| Assets, bln rub | 119 307 | 117 208 | 117 208 | 120 829 | 120 829 | 119 598 | ||||
| Net Assets, bln rub | ? | 46 654 | 46 854 | 46 854 | 47 065 | 47 065 | 50 058 | |||
| Debt, bln rub | 31 988 | 31 493 | 31 493 | 34 607 | 34 607 | 31 982 | ||||
| Cash, bln rub | 10 288 | 7 214 | 7 214 | 8 246 | 8 246 | 6 828 | ||||
| Net debt, bln rub | 21 700 | 24 279 | 24 279 | 26 361 | 26 361 | 25 154 | ||||
| Ordinary share price, rub | 134.9 | 143.8 | 143.8 | 151.7 | 151.7 | 151.4 | ||||
| Number of ordinary shares, mln | 2 466 | 2 539 | 2 410 | 2 414 | 2 368 | 2 361 | ||||
| Market cap, bln rub | 332 710 | 365 097 | 346 577 | 366 301 | 359 351 | 357 262 | ||||
| EV, bln rub | ? | 354 410 | 389 376 | 370 856 | 392 662 | 385 712 | 382 416 | |||
| Book value, bln rub | -17 912 | -16 525 | -16 525 | -17 377 | -17 377 | -12 701 | ||||
| EPS, rub | ? | 5.80 | 5.81 | 6.12 | 6.07 | 6.19 | 6.41 | |||
| FCF/share, rub | 6.32 | 5.34 | 5.63 | 5.71 | 5.82 | 6.85 | ||||
| BV/share, rub | -7.26 | -6.51 | -6.86 | -7.20 | -7.34 | -5.38 | ||||
| EBITDA margin, % | ? | 27.4% | 26.4% | 26.5% | 26.6% | 26.6% | 28.2% | |||
| Net margin, % | ? | 18.8% | 18.4% | 18.4% | 17.9% | 17.9% | 18.0% | |||
| FCF yield, % | ? | 4.68% | 3.72% | 3.91% | 3.76% | 3.84% | 4.52% | |||
| ROE, % | ? | 30.7% | 31.5% | 31.5% | 31.1% | 31.1% | 30.2% | |||
| ROA, % | ? | 12.0% | 12.6% | 12.6% | 12.1% | 12.1% | 12.6% | |||
| P/E | ? | 23.3 | 24.8 | 23.5 | 25.0 | 24.5 | 23.6 | |||
| P/FCF | 21.3 | 26.9 | 25.5 | 26.6 | 26.1 | 22.1 | ||||
| P/S | ? | 4.37 | 4.55 | 4.32 | 4.47 | 4.38 | 4.25 | |||
| P/BV | ? | -18.6 | -22.1 | -21.0 | -21.1 | -20.7 | -28.1 | |||
| EV/EBITDA | ? | 17.0 | 18.4 | 17.5 | 18.0 | 17.7 | 16.1 | |||
| Debt/EBITDA | 1.04 | 1.15 | 1.14 | 1.21 | 1.21 | 1.06 | ||||
| R&D/CAPEX, % | 68.2% | 0.00% | 63.4% | 0.00% | 65.3% | 61.1% | ||||
| CAPEX/Revenue, % | 3.66% | 3.94% | 3.94% | 3.73% | 3.73% | 3.89% | ||||
| Procter & Gamble shareholders | ||||||||||
